Letters
β blockers and mortality in COPD
Author’s reply to Wolstenholme and Sanfilippo and colleagues
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1132 (Published 29 January 2014) Cite this as: BMJ 2014;348:g1132
- Jennifer K Quint, clinical lecturer and honorary consultant1
- 1Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
- jennifer.quint{at}lshtm.ac.uk
The responders have highlighted some important issues that merit further investigation.1 2 3 4
We agree with Wolstenholme that it seems counterintuitive to use β blockers and β agonists in patients with chronic obstructive pulmonary disease (COPD), but most patients in our study were prescribed cardioselective β blockers, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.